<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04618354</url>
  </required_header>
  <id_info>
    <org_study_id>LADA</org_study_id>
    <nct_id>NCT04618354</nct_id>
  </id_info>
  <brief_title>Comparing the Clinical Characteristics of Male LADA, T1DM and T2DM Patients</brief_title>
  <acronym>LADA</acronym>
  <official_title>Comparing the Clinical Characteristics of Male Patients With Latent Autoimmune Diabetes ,Classic Type 2 Diabetes and Classic Type 2 Diabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shanghai 10th People's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shanghai 10th People's Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Diabetes is a common chronic disease in most parts of the world. Diabetes-related&#xD;
      complications are harmful to the human body. Different types of diabetes have different&#xD;
      levels of harm to the human body. There are also fewer studies on the relationship between&#xD;
      specific types of diabetes and clinical diseases such as osteoporosis and Hypogonadism.&#xD;
      Therefore, clarifying the differences in the clinical characteristics of adult men with&#xD;
      late-onset autoimmune diabetes (LADA) ,Classical type 1 diabetes (T1DM) and type 2 diabetes&#xD;
      (T2DM) will help to further understand the effects of diabetes on bone metabolism and sex&#xD;
      hormones.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Diabetes is a common chronic disease in most parts of the world. Diabetes-related&#xD;
      complications are harmful to the human body. There are also fewer studies on the relationship&#xD;
      between specific types of diabetes and clinical diseases such as osteoporosis and&#xD;
      Hypogonadism. This study aimed to compare the prevalence of hypogonadism and osteoporosis&#xD;
      among male patients with latent autoimmune diabetes (LADA), type 1 diabetes (T1DM) and type 2&#xD;
      diabetes (T2DM) and investigate the protective factors for hypogonadism and osteoporosis in&#xD;
      these patients. This cross-sectional study evaluated male patients with LADA, T1DM, and T2DM&#xD;
      who visited the endocrinology department of Shanghai Tenth People's Hospital for diabetes&#xD;
      management. Sex hormones, lipid profiles, sex hormone-binding globulin (SHBG), glycosylated&#xD;
      hemoglobin A1c, beta-cell function, uric acid, and osteocalcin were determined in serum&#xD;
      samples. Therefor，clarifying the differences in the clinical characteristics of adult men&#xD;
      with LADA, T1DM and T2DM will help to further understand the effects of diabetes on bone&#xD;
      metabolism and sex hormones.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2019</start_date>
  <completion_date type="Actual">December 30, 2020</completion_date>
  <primary_completion_date type="Actual">November 30, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Testosterone</measure>
    <time_frame>2016-2021</time_frame>
    <description>total testosterone (nmol/L), testosterone (nmol/L) and SHBG (nmol/L). Hypogonadism was defined as total testosterone levels less than 3.0 ng/ml</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Bone mineral density</measure>
    <time_frame>2016-2021</time_frame>
    <description>Bone mineral density was measured at the lumbar spine, femoral neck, and right hip by dual-energy x-ray absorptiometry (DXA)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>HbA1c</measure>
    <time_frame>2016-2021</time_frame>
    <description>Glycosylated hemoglobin A1c</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>FBG</measure>
    <time_frame>2016-2021</time_frame>
    <description>patients with fasting blood glucose 6.1mmol/l or more</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PBG</measure>
    <time_frame>2016-2021</time_frame>
    <description>patients with 2 hour blood glucose 7.8mmol/l or more</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>FINS</measure>
    <time_frame>2016-2021</time_frame>
    <description>metabolic profile fasting insulin (IU/L)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PINS</measure>
    <time_frame>2016-2021</time_frame>
    <description>patients with 2 hour blood insulin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>TC</measure>
    <time_frame>2016-2021</time_frame>
    <description>metabolic profile Total cholesterol (mmol/L)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>TG</measure>
    <time_frame>2016-2021</time_frame>
    <description>metabolic profile Triglycerides (mmol/L)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HDL-c</measure>
    <time_frame>2016-2021</time_frame>
    <description>metabolic profile high-density lipoprotein cholesterol (mmol/L)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>LDL-c</measure>
    <time_frame>2016-2021</time_frame>
    <description>metabolic profile Low-density lipoprotein cholesterol (mmol/L)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>FSH</measure>
    <time_frame>2016-2021</time_frame>
    <description>follicle-stimulating hormone</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>LH</measure>
    <time_frame>2016-2021</time_frame>
    <description>luteinizing hormone</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">632</enrollment>
  <condition>Diabetes</condition>
  <arm_group>
    <arm_group_label>LADA group</arm_group_label>
    <description>The patient was diagnosed with late-onset autoimmune diabetes (LADA).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>T2DM group</arm_group_label>
    <description>The patient was diagnosed with type 2 diabetes (T2DM).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>T1DM group</arm_group_label>
    <description>The patient was diagnosed with type 1 diabetes (T1DM).</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No interventions</intervention_name>
    <description>This clinical study is a retrospective study, and no interventions have been implemented for patients.</description>
    <arm_group_label>LADA group</arm_group_label>
    <arm_group_label>T1DM group</arm_group_label>
    <arm_group_label>T2DM group</arm_group_label>
  </intervention>
  <biospec_retention>None Retained</biospec_retention>
  <biospec_descr>
    <textblock>
      Take a blood sample from the patient and extract serum from it for testing&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        600 diabetes Patients from Shanghai Tenth People's Hospital were enrolled in this study.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. 30 ~ 80 years old male;&#xD;
&#xD;
          2. Meet the American Diabetes Association (ADA) definition and standards for diabetes&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. having diseases that affect bone and calcium metabolism, such as hyperthyroidism,&#xD;
             hyperparathyroidism, hypogonadism, cushing syndrome, rheumatoid arthritis, cirrhosis,&#xD;
             or malignant tumor;&#xD;
&#xD;
          2. the use in the past 6 months of drugs that interfere with bone and calcium metabolism,&#xD;
             such as sex steroids, vitamin D metabolites, calcitonin, bisphosphonates, and thyroid&#xD;
             hormone;&#xD;
&#xD;
          3. moderate or severe liver and renal dysfunction, including serum alanine&#xD;
             aminotransferase of 120 IU/L, aspartate aminotransferase of 80 IU/L, and serum&#xD;
             creatinine of 120 μmol/L.&#xD;
&#xD;
        4）a history of congenital/hypogonadotropic hypogonadism or hyperthyroidism, or those who&#xD;
        received testosterone replacement therapy in the past 6 months were excluded.&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shen Qu, Dr</last_name>
    <role>Study Chair</role>
    <affiliation>Shang hai Tenth People's Hospital, Shanghai, Shanghai, China, 200072</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Endocrinology, Shanghai Tenth People's Hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200070</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Cai M, Cui R, Yang P, Gao J, Cheng X, Sheng C, Li H, Sheng H, Qu S, Zhang M. Incidence and Risk Factors of Hypogonadism in Male Patients With Latent Autoimmune Diabetes and Classic Type 2 Diabetes. Front Endocrinol (Lausanne). 2021 May 31;12:675525. doi: 10.3389/fendo.2021.675525. eCollection 2021.</citation>
    <PMID>34135863</PMID>
  </reference>
  <reference>
    <citation>Zhang M, Sheng C, You H, Cai M, Gao J, Cheng X, Sheng H, Qu S. Comparing the bone mineral density among male patients with latent autoimmune diabetes and classical type 1 and type 2 diabetes, and exploring risk factors for osteoporosis. J Endocrinol Invest. 2021 Aug;44(8):1659-1665. doi: 10.1007/s40618-020-01472-6. Epub 2021 Jan 2.</citation>
    <PMID>33387352</PMID>
  </reference>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>October 31, 2020</study_first_submitted>
  <study_first_submitted_qc>October 31, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 5, 2020</study_first_posted>
  <last_update_submitted>July 12, 2021</last_update_submitted>
  <last_update_submitted_qc>July 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Shanghai 10th People's Hospital</investigator_affiliation>
    <investigator_full_name>Zhang Manna</investigator_full_name>
    <investigator_title>Director, Principal Investigator, Clinical Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

